[Surgical reconstruction of the injured upper ankle joint--correct and incorrect technics].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4632861)

Published in Arch Orthop Unfallchir on January 01, 1973

Authors

M Weigert, G Friedebold, H Klems, H Pachowsky, J Luhnau

Articles by these authors

Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1984) 5.49

Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49

Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78

Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med (1990) 4.46

Genetics of the antibody response to dextran in mice. Science (1972) 4.37

Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature (1981) 4.19

Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54

Transcription of mouse kappa chain genes: implications for allelic exclusion. Proc Natl Acad Sci U S A (1980) 3.38

Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32

Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24

Rearrangement of genetic information may produce immunoglobulin diversity. Nature (1979) 2.84

Transcription of the unrearranged mouse C kappa locus: sequence of the initiation region and comparison of activity with a rearranged V kappa-C kappa gene. Cell (1981) 2.80

B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78

Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity (1995) 2.56

Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 2.45

Residues that mediate DNA binding of autoimmune antibodies. J Immunol (1993) 2.37

DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A (1982) 2.36

Genetic control of antibody variable regions. Cold Spring Harb Symp Quant Biol (1977) 2.35

The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28

Immunochemical analysis of the cross-reacting idiotypes of mouse myeloma proteins with anti-dextran activity and normal anti-dextran antibody. Proc Natl Acad Sci U S A (1973) 2.21

Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. Nature (1975) 2.01

A 4-methoxybenzoate O-demethylase from Pseudomonas putida. A new type of monooxygenase system. Eur J Biochem (1975) 1.97

Revising B cell receptors. J Exp Med (2000) 1.96

Ig H and L chain contributions to autoimmune specificities. J Immunol (1991) 1.96

Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90

Editors and editing of anti-DNA receptors. Immunity (2001) 1.90

The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87

Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity. Nature (1979) 1.85

Editing disease-associated autoantibodies. Immunity (1997) 1.81

Mouse lambda-chain sequences. Proc Natl Acad Sci U S A (1973) 1.78

How immunoglobulin V kappa genes rearrange. J Immunol (1987) 1.68

Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68

Deletion and editing of B cells that express antibodies to DNA. J Immunol (1994) 1.62

A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol (1997) 1.58

Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). II. Comparison of hybridomas derived by lipopolysaccharide stimulation and secondary protein immunization. J Exp Med (1987) 1.43

Light chain contribution to specificity in anti-DNA antibodies. J Immunol (1995) 1.39

Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med (1999) 1.36

Structural patterns in anti-DNA antibodies from MRL/lpr mice. Cold Spring Harb Symp Quant Biol (1989) 1.35

The BALB/c secondary response to the Sb site of influenza virus hemagglutinin. Nonrandom silent mutation and unequal numbers of VH and Vk mutations. J Immunol (1990) 1.30

Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29

Chromosomal locations of mouse immunoglobulin genes. Proc Natl Acad Sci U S A (1978) 1.29

Mouse immunoglobulin heavy chains are coded by multiple germ line variable region genes. Proc Natl Acad Sci U S A (1974) 1.22

Immunoglobulins with hapten-binding activity: structure-function correlations and genetic implications. Eur J Immunol (1978) 1.22

New methods for the treatment of lunatomalacia. Reconstr Surg Traumatol (1969) 1.22

Immunochemical analysis of the idiotypes of mouse myeloma proteins with specificity for levan or dextran. J Exp Med (1974) 1.20

Heavy-chain class switch does not terminate somatic mutation. J Exp Med (1990) 1.16

Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci U S A (2001) 1.15

Origins of anti-DNA antibodies and their implications for B-cell tolerance. Ann N Y Acad Sci (1995) 1.15

Aberrant rearrangement of the kappa light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature (1983) 1.14

Reorganization and expression of immunoglobulin genes: status of allelic elements. Cold Spring Harb Symp Quant Biol (1981) 1.12

[Errors and hazards in total hip-joint prosthesis]. Z Orthop Ihre Grenzgeb (1971) 1.10

Genetics of mouse antibodies. II. Recombination between VH genes and allotype. Eur J Immunol (1975) 1.10

Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol (1992) 1.09

Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09

Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines. J Immunol (1980) 1.09

Myeloma proteins from NZB and BALB/c mice: structural and functional differences. Proc Natl Acad Sci U S A (1979) 1.07

Genetic polymorphism at the kappa chain locus in mice: comparisons of restriction enzyme hybridization fragments of variable and constant region genes. Immunogenetics (1985) 1.02

Independent segregation of NZB immune abnormalities in NZB x C58 recombinant inbred mice. Eur J Immunol (1982) 1.02

[Simple procedure for the surgical management of habitual peroneal tendon luxation]. Z Orthop Ihre Grenzgeb (1968) 0.98

The idiotypes of V kappa 21 light chains. Ann Immunol (Paris) (1984) 0.97

Amplification of immunoglobulin lambda constant genes in populations of wild mice. Nature (1982) 0.96

[Sources of error in alloarthroplasties of the hip and their prevention]. Z Orthop Ihre Grenzgeb (1969) 0.95

Replication pattern in XXY cells with fra(X). Hum Genet (1982) 0.92

[Stimulation of bone formation using electrical current]. Hefte Unfallheilkd (1973) 0.92

Expression of kappa chains of the V kappa 21 group in Mus musculus and related species. Mol Immunol (1981) 0.91

[Total alloarthroplasty following arthrodesis]. Z Orthop Ihre Grenzgeb (1971) 0.91

[Advances in the technique of arthrodesis of the hip]. Munch Med Wochenschr (1968) 0.90

[Pathophysiology and pathomechanics of the shoulder girdle]. Hefte Unfallheilkd (1982) 0.89

[Chondromalacia patellae in the active sportsman]. Z Orthop Ihre Grenzgeb (1968) 0.89

A solution to the rheumatoid factor paradox: pathologic rheumatoid factors can be tolerized by competition with natural rheumatoid factors. J Immunol (1997) 0.89

[Potentials in bone on electric stimulation (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.88

[Possibilities and limitations in the surgical management of malignant mesenchymal tumors of the locomotor apparatus]. Z Orthop Ihre Grenzgeb (1968) 0.88

[Injuries of the knee ligaments: suture or plastic repair]. Arch Orthop Unfallchir (1972) 0.87

[The speed of nerve-conduction after micro-surgical suture of the tibial nerve of the rabbit (author's transl)]. Z Orthop Ihre Grenzgeb (1975) 0.87

Plasmacytomas of the NZB mouse. J Immunol (1978) 0.87

[Shoulder joint replacement]. Arch Orthop Unfallchir (1973) 0.87

[The regression of neurological symptoms following intervertebral disk surgery]. Z Orthop Ihre Grenzgeb (1967) 0.86

[Injury of the distal tibiofibular syndesmosis, its diagnosis and treatment]. Z Orthop Ihre Grenzgeb (1967) 0.85

[Arthrodesis in tabetic arthropathy]. Arch Orthop Unfallchir (1966) 0.85

Phospholipid metabolism in embryonic rat fibroblasts following stimulation by a combination of the serum proteins S1 and S2. Eur J Biochem (1974) 0.85

Evaluation of the effect of isometric training in functional and organic muscle atrophy. Arch Phys Med Rehabil (1968) 0.84

Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer. J Assist Reprod Genet (2000) 0.84

Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J Immunol (1995) 0.84

The structural basis of antigenic determinants on V kappa 21 light chains. Mol Immunol (1981) 0.83

[Radius-shortening osteotomy in os lunatum malacia]. Munch Med Wochenschr (1967) 0.82

[Influence upon the longitudinal growth of extremities by direct current in animal experiments (author's transl)]. Z Orthop Ihre Grenzgeb (1981) 0.82

[Experience with Chiari pelvic osteotomy in the adult (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.82

Influence of potassium and calcium ions on the phosphatidylinositol and phosphatidylcholine metabolism in rat fibroblasts after growth stimulation by calf serum. Eur J Biochem (1975) 0.82

Fixing mismatches. Science (1998) 0.81

[Rupture of the abdominal aorta following a corrective spinal operation for ankylopoeitic spondylitis]. Z Orthop Ihre Grenzgeb (1971) 0.81

[Proceedings: Typology of vertebral fractures]. Z Orthop Ihre Grenzgeb (1974) 0.81

[Severe pelvic fractures and the right time for their treatment]. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed (1971) 0.80

[Results and complications following endoprosthesis operations on the hip]. Z Orthop Ihre Grenzgeb (1969) 0.80

[Progresses in the orthopedic-reconstructive surgery by microsurgery (author's transl)]. Z Orthop Ihre Grenzgeb (1979) 0.80

[Fractures of the metacarpal bones II to V--conservative and surgical treatment]. Unfallchirurgie (1985) 0.79

[Bilateral thrombosis of the popliteal vein with diffuse muscular necrosis following CO intoxication]. Dtsch Med Wochenschr (1969) 0.79